Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Signal Transduct Target Ther ; 6(1): 165, 2021 04 24.
Artigo em Inglês | MEDLINE | ID: mdl-33895786

RESUMO

The global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requires an urgent need to find effective therapeutics for the treatment of coronavirus disease 2019 (COVID-19). In this study, we developed an integrative drug repositioning framework, which fully takes advantage of machine learning and statistical analysis approaches to systematically integrate and mine large-scale knowledge graph, literature and transcriptome data to discover the potential drug candidates against SARS-CoV-2. Our in silico screening followed by wet-lab validation indicated that a poly-ADP-ribose polymerase 1 (PARP1) inhibitor, CVL218, currently in Phase I clinical trial, may be repurposed to treat COVID-19. Our in vitro assays revealed that CVL218 can exhibit effective inhibitory activity against SARS-CoV-2 replication without obvious cytopathic effect. In addition, we showed that CVL218 can interact with the nucleocapsid (N) protein of SARS-CoV-2 and is able to suppress the LPS-induced production of several inflammatory cytokines that are highly relevant to the prevention of immunopathology induced by SARS-CoV-2 infection.


Assuntos
Antivirais/uso terapêutico , COVID-19/tratamento farmacológico , COVID-19/metabolismo , Simulação por Computador , Reposicionamento de Medicamentos , Modelos Biológicos , SARS-CoV-2/metabolismo , Humanos
2.
ACS Appl Mater Interfaces ; 13(3): 4062-4071, 2021 Jan 27.
Artigo em Inglês | MEDLINE | ID: mdl-33428393

RESUMO

Aprotic lithium-oxygen batteries currently suffer from poor cyclic stability and low achievable energy density. Herein, gold nanoparticles capped with mercaptosuccinic acid are dispersed in 1.0 M LiClO4/dimethyl sulfoxide (DMSO) as a novel electrolyte for lithium-oxygen batteries. Morphological and electrochemical analyses indicate that film-like amorphous lithium peroxide is formed using the gold nanocolloid electrolyte instead of bulk crystals in battery discharging, which apparently increases the conductivity and accelerates the decomposition kinetics of discharge products in recharging, accompanied by the release of incorporated gold nanoparticles with the decomposition of lithium peroxide into the electrolyte. Experiments and theoretical calculations further demonstrate that the suspended gold nanoparticles in the electrolyte can adsorb some intermediates generated by an oxygen reduction reaction, which effectively alleviates the cleavage of the electrolyte and impedes the corrosion of the lithium anode. As a result, the life span of lithium-oxygen batteries is dramatically increased from 55 to 438 cycles, and the rate performance and full-discharge capacity are also massively enhanced. The battery failure is attributed to the degradation of gold nanocolloid electrolytes, and further studies on improvement of colloid stability during battery cycling are underway.

3.
Brain Res Bull ; 162: 141-150, 2020 09.
Artigo em Inglês | MEDLINE | ID: mdl-32540419

RESUMO

Alzheimer's disease (AD) is characterized by deposition of ß-amyloid protein (Aß), neurofibrillary tangles and cognitive deficits resulting from neuronal cell death. In search for the molecular underpinnings of the disease, we were interested in the relationship between Aß, L1 cell adhesion molecule and protein kinase D1 (PKD1), which are not only implicated in neural development and functional maintenance in the adult, but are also neuroprotective under pathological conditions. Based on our observations that L1 and phosphorylated, i.e. activated, protein kinase PKD1 (pPKD1) co-localize in cultured neurons, we investigated the functional relationship between L1 and pPKD1 in the frontal lobe of an AD human cortical tissue microarray, and found increased and positively correlating levels of both molecules when compared to a non-affected human brain. Also in the APPSWE mouse model of AD, L1 and pPKD1 levels were increased in the frontal lobe. To investigate whether L1 influences PKD1-based functions in AD, cultured cortical neurons were stressed with either H2O2 or oligomeric Aß1-42, in the presence or absence of recombinant L1 extracellular domain, and PKD1 phosphorylation was measured. As indicated by the cell viability assay, L1 maintained neuronal survival under oxidative stress and under application of oligomeric Aß1-42, when PKD1 activity was inhibited, suggesting that L1 ameliorates some aspects of Aß1-42 pathology in parallel with reducing PKD1 function.


Assuntos
Doença de Alzheimer/metabolismo , Córtex Cerebral/metabolismo , Molécula L1 de Adesão de Célula Nervosa/metabolismo , Proteína Quinase C/metabolismo , Doença de Alzheimer/genética , Doença de Alzheimer/patologia , Precursor de Proteína beta-Amiloide/genética , Animais , Córtex Cerebral/patologia , Ativação Enzimática/fisiologia , Feminino , Humanos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Molécula L1 de Adesão de Célula Nervosa/genética , Proteína Quinase C/genética
4.
Asian J Pharm Sci ; 15(2): 131-144, 2020 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-32373195

RESUMO

Solute carriers (SLCs) are the largest family of transmembrane transporters that determine the exchange of various substances, including nutrients, ions, metabolites, and drugs across biological membranes. To date, the presence of about 287 SLC genes have been identified in the brain, among which mutations or the resultant dysfunctions of 71 SLC genes have been reported to be correlated with human brain disorders. Although increasing interest in SLCs have focused on drug development, SLCs are currently still under-explored as drug targets, especially in the brain. We summarize the main substrates and functions of SLCs that are expressed in the brain, with an emphasis on selected SLCs that are important physiologically, pathologically, and pharmacologically in the blood-brain barrier, astrocytes, and neurons. Evidence suggests that a fraction of SLCs are regulated along with the occurrences of brain disorders, among which epilepsy, neurodegenerative diseases, and autism are representative. Given the review of SLCs involved in the onset and procession of brain disorders, we hope these SLCs will be screened as promising drug targets to improve drug delivery to the brain.

5.
Curr Alzheimer Res ; 17(4): 382-392, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32321402

RESUMO

BACKGROUND: Cognitive capacities in Alzheimer's Disease (AD) are impaired by an epigenetic blockade mediated by histone deacetylase 2 (HDAC2), which prevents the transcription of genes that are important for synaptic plasticity. OBJECTIVE: Investigation of the functional relationship between cell adhesion molecule L1 and HDAC2 in AD. METHODS: Cultures of dissociated cortical and hippocampal neurons from wild-type or L1-deficient mice were treated with Aß1-42 for 24 h. After removal of Aß1-42 cells were treated with the recombinant L1 extracellular domain (rL1) for 24 h followed by immunohistochemistry, western blotting, and reverse transcription PCR to evaluate the interaction between L1 and HDAC2. RESULTS: Aß and HDAC2 protein levels were increased in APPSWE/L1+/- mutant brains compared to APPSWE mutant brains. Administration of the recombinant extracellular domain of L1 to cultured cortical and hippocampal neurons reduced HDAC2 mRNA and protein levels. In parallel, reduced phosphorylation levels of glucocorticoid receptor 1 (GR1), which is implicated in regulating HDAC2 levels, was observed in response to L1 administration. Application of a glucocorticoid receptor inhibitor reduced Aß-induced GR1 phosphorylation and prevented the increase in HDAC2 levels. HDAC2 protein levels were increased in cultured cortical neurons from L1-deficient mice. This change could be reversed by the administration of the recombinant extracellular domain of L1. CONCLUSION: Our results suggest that some functionally interdependent activities of L1 and HDAC2 contribute to ameliorating the phenotype of AD by GR1 dephosphorylation, which leads to reduced HDAC2 expression. The combined findings encourage further investigations on the beneficial effects of L1 in the treatment of AD.


Assuntos
Doença de Alzheimer/metabolismo , Regulação Enzimológica da Expressão Gênica , Histona Desacetilase 2/biossíntese , Molécula L1 de Adesão de Célula Nervosa/administração & dosagem , Molécula L1 de Adesão de Célula Nervosa/deficiência , Doença de Alzheimer/induzido quimicamente , Doença de Alzheimer/patologia , Peptídeos beta-Amiloides/toxicidade , Animais , Células Cultivadas , Feminino , Hipocampo/metabolismo , Hipocampo/patologia , Histona Desacetilase 2/antagonistas & inibidores , Masculino , Camundongos , Camundongos da Linhagem 129 , Camundongos Endogâmicos C57BL , Camundongos Knockout , Camundongos Transgênicos , Fragmentos de Peptídeos/toxicidade
6.
BMC Cancer ; 19(1): 911, 2019 Sep 12.
Artigo em Inglês | MEDLINE | ID: mdl-31510944

RESUMO

BACKGROUND: Gliomas account for the majority of primary human brain tumors and remain a challenging neoplasm for cure due to limited therapeutic options. Cell adhesion molecules play pivotal roles in the growth and progression of glial tumors. Roles of the adhesion molecules on glia (AMOG) and L1CAM (L1) in glioma cells have been shown to correlate with tumorigenesis: Increased expression of L1 and decreased expression of AMOG correlate with degree of malignancy. METHODS: We evaluated the interdependence in expression of these molecules by investigating the role of AMOG in vitro via modulation of L1 expression and analyzing apoptosis and cell senescence of glioma cells. RESULTS: Immunohistochemical staining of normal human cortical and glioma tissue microarrays demonstrated that AMOG expression was lower in human gliomas compared to normal tissue and is inversely correlated with the degree of malignancy. Moreover, reduction of AMOG expression in human glioblastoma cells elevated L1 expression, which is accompanied by decreased cell apoptosis as well as senescence. CONCLUSION: AMOG and L1 interdependently regulate their expression levels not only in U-87 MG cells but also in U251 and SHG44 human glioma cell lines. The capacity of AMOG to reduce L1 expression suggests that methods for increasing AMOG expression may provide a therapeutic choice for the management of glial tumors with high expression of L1.


Assuntos
Adenosina Trifosfatases/genética , Neoplasias Encefálicas/genética , Proteínas de Transporte de Cátions/genética , Moléculas de Adesão Celular Neuronais/genética , Regulação Neoplásica da Expressão Gênica , Glioblastoma/genética , Molécula L1 de Adesão de Célula Nervosa/genética , Adenosina Trifosfatases/metabolismo , Apoptose/genética , Biomarcadores , Neoplasias Encefálicas/metabolismo , Proteínas de Transporte de Cátions/metabolismo , Adesão Celular/genética , Moléculas de Adesão Celular Neuronais/metabolismo , Linhagem Celular Tumoral , Senescência Celular/genética , Perfilação da Expressão Gênica , Glioblastoma/metabolismo , Humanos , Imuno-Histoquímica , Molécula L1 de Adesão de Célula Nervosa/metabolismo , RNA Interferente Pequeno/genética , Transdução de Sinais
7.
Sci Rep ; 9(1): 1064, 2019 01 31.
Artigo em Inglês | MEDLINE | ID: mdl-30705359

RESUMO

Chondroitin sulfate proteoglycans (CSPGs), up-regulated in and around the glial scar after mammalian spinal cord injury, have been suggested to be key inhibitory molecules for functional recovery by impeding axonal regrowth/sprouting and synaptic rearrangements. CSPG-mediated inhibition is mainly associated with the glycosaminoglycan chains of CSPGs, and chondroitin-4-sulfate (C4S) is the predominant sulfated structure that regulates axonal guidance and growth in the adult nervous system. With the aim to find molecules that neutralize the inhibitory functions of C4S, we screened a phage display library for peptides binding to C4S. From the phage clones binding to C4S we selected three peptides for further analysis. We observed that these peptides bind to C4S, but not chondroitin-6-sulfate, heparin sulfate or dermatan sulfate, in a concentration-dependent and saturable manner, whereas the scrambled peptides showed highly reduced or no binding to C4S. The C4S-binding peptides, but not their scrambled counterparts, when added to cultures of mouse cerebellar neurons and human neuroblastoma cells, neutralized the inhibitory functions of the C4S- and CSPG-coated substrate on cell adhesion, neuronal migration and neurite outgrowth. These results indicate that the C4S-binding peptides neutralize several inhibitory functions of CSPGs, suggesting that they may be beneficial in repairing mammalian nervous system injuries.


Assuntos
Cerebelo , Sulfatos de Condroitina/química , Neurônios , Biblioteca de Peptídeos , Animais , Adesão Celular , Linhagem Celular Tumoral , Movimento Celular , Cerebelo/química , Cerebelo/metabolismo , Humanos , Camundongos , Neurônios/química , Neurônios/metabolismo
8.
Front Mol Neurosci ; 10: 324, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-29089868

RESUMO

The cell adhesion molecule with homology to L1CAM (close homolog of L1) (CHL1) is a member of the cell adhesion molecule L1 (L1CAM) gene family. Although CHL1 expression and function have been reported in several tumors, the roles of CHL1 in the development of glioma remain unclear. In the present study, we investigated the effects of CHL1 on proliferation indexes and activation of Akt1 and Erk signaling by siRNA in U-87 MG human glioblastoma and human U251 and SHG-44 glioma cells. We found that siRNA targeting CHL1 significantly down-regulated the expression of CHL1 mRNA and protein accompanied by reduced cell proliferation and transmigration invasion in all three cell lines. Down-regulating CHL1 expression also reduced cell survival, as measured by the Bax/Bcl-2 ratio, and increased activation of caspase-3. In subcutaneous U-87 MG cell xenograft tumors in nude mice, intratumoral administration of siRNA targeting CHL1 treatment significantly down-regulated CHL1 expression in vivo, accompanied by increased levels of activated caspase-3. Our combined results confirmed for the first time that in contrast to findings about CHL1 in most other cancer types, CHL1 functions in promoting cell proliferation, metastasis and migration in human glioma cells both in vitro and in vivo. These results indicate that CHL1 is a therapeutic target in the clinical management of glioma/glioblastoma.

9.
Dis Model Mech ; 10(9): 1117-1128, 2017 09 01.
Artigo em Inglês | MEDLINE | ID: mdl-28714852

RESUMO

Curing spinal cord injury (SCI) in mammals is a daunting task because of the lack of permissive mechanisms and strong inhibitory responses at and around the lesion. The neural cell adhesion molecule L1CAM (L1) has been shown to favor axonal regrowth and enhance neuronal survival and synaptic plasticity but delivery of full-length L1 or its extracellular domain could encounter difficulties in translation to therapy in humans. We have, therefore, identified several small organic compounds that bind to L1 and stimulate neuronal survival, neuronal migration and neurite outgrowth in an L1-dependent manner. Here, we assessed the functions of two L1 mimetics, trimebutine and honokiol, in regeneration following SCI in young adult mice. Using the Basso Mouse Scale (BMS) score, we found that ground locomotion in trimebutine-treated mice recovered better than honokiol-treated or vehicle-receiving mice. Enhanced hindlimb locomotor functions in the trimebutine group were observed at 6 weeks after SCI. Immunohistology of the spinal cords rostral and caudal to the lesion site showed reduced areas and intensities of glial fibrillary acidic protein immunoreactivity in both trimebutine and honokiol groups, whereas increased regrowth of axons was observed only in the trimebutine-treated group. Both L1- and L1 mimetic-mediated intracellular signaling cascades in the spinal cord lesion sites were activated by trimebutine and honokiol, with trimebutine being more effective than honokiol. These observations suggest that trimebutine and, to a lesser extent under the present experimental conditions, honokiol have a potential for therapy in regeneration of mammalian spinal cord injuries.


Assuntos
Molécula L1 de Adesão de Célula Nervosa/agonistas , Recuperação de Função Fisiológica/efeitos dos fármacos , Bibliotecas de Moléculas Pequenas/uso terapêutico , Traumatismos da Medula Espinal/tratamento farmacológico , Traumatismos da Medula Espinal/fisiopatologia , Trimebutina/uso terapêutico , Animais , Compostos de Bifenilo/farmacologia , Compostos de Bifenilo/uso terapêutico , Células Cultivadas , Cerebelo/patologia , Feminino , Proteína Glial Fibrilar Ácida/metabolismo , Gliose/complicações , Gliose/tratamento farmacológico , Gliose/patologia , Gliose/fisiopatologia , Filamentos Intermediários/efeitos dos fármacos , Filamentos Intermediários/metabolismo , Lignanas/farmacologia , Lignanas/uso terapêutico , Locomoção/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos C57BL , Molécula L1 de Adesão de Célula Nervosa/metabolismo , Neurônios/efeitos dos fármacos , Neurônios/metabolismo , Neurônios/patologia , Transdução de Sinais/efeitos dos fármacos , Bibliotecas de Moléculas Pequenas/farmacologia , Traumatismos da Medula Espinal/complicações , Traumatismos da Medula Espinal/patologia , Trimebutina/farmacologia , Tubulina (Proteína)/metabolismo
10.
Brain Res ; 1670: 32-43, 2017 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-28623147

RESUMO

Cerebellum undergoes degenerative changes in neurodegenerative diseases. Two main factors including oxidative stress and neuroinflammation mediate neurodegeneration. Neuregulin-1 (Nrg1) has been implicated in many neurodegenerative diseases, while the underlying mechanisms are unknown. We hypothesized that Nrg1 prevents oxidative stress and neuroinflammation in neurodegeneration. We found a positive correlation between Nrg1 protein levels and ErbB4 and ErbB2 receptor phosphorylation in microarrays of normal human cerebellar tissue. In addition, Nrg1 was also co-localized with pErbB4 and pErbB2. Primary mouse cerebellar granule neurons (CGNs) were treated with H2O2 or LPS combined with recombinant Nrg1ß (rNrg1ß). Western blot analysis and immunofluorescence revealed that H2O2 and LPS-induced neuronal toxicity down-regulated the activation of ErbB receptors and Akt1, and the ratio of Bcl2/Bax, which was reversed by rNrg1ß. In vivo studies showed that LPS-induced neuroinflammation in mouse cerebellum down-regulated pErbB4, pErbB2, pAkt1/Akt1 and Bcl2/Bax levels, whereas rNrg1ß treatment reversed the changes. Immunohistochemistry and Western blot analysis showed that rNrg1ß alleviates neuroinflammation by reducing the number of microglial cells and astrocytes and the expression of IL1ß. Our results indicate that Nrg1 protects against oxidative stress and neuroinflammation in mouse cerebellum, suggesting potential therapeutic application in neuroinflammation associated with neurodegenerative diseases.


Assuntos
Cerebelo/efeitos dos fármacos , Neuregulina-1/farmacologia , Animais , Feminino , Humanos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Neuroimunomodulação/efeitos dos fármacos , Neuroimunomodulação/fisiologia , Neurônios/metabolismo , Fármacos Neuroprotetores/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Estresse Oxidativo/fisiologia , Fosforilação , Cultura Primária de Células , Análise Serial de Proteínas/métodos , Proteínas Proto-Oncogênicas c-akt/metabolismo , Receptor ErbB-2/efeitos dos fármacos , Receptor ErbB-4/efeitos dos fármacos , Transdução de Sinais/efeitos dos fármacos
11.
Mol Med Rep ; 14(3): 2614-24, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-27486021

RESUMO

Alzheimer's disease (AD), one of the neurodegenerative disorders that may develop in the elderly, is characterized by the deposition of ß­amyloid protein (Aß) and extensive neuronal cell death in the brain. Neuregulin­1 (Nrg1)­mediated intercellular and intracellular communication via binding to ErbB receptors regulates a diverse set of biological processes involved in the development of the nervous system. In the present study, a linear correlation was identified between Nrg1 and phosphorylated ErbB (pNeu and pErbB4) receptors in a human cortical tissue microarray. In addition, increased expression levels of Nrg1, but reduced pErbB receptor levels, were detected in the frontal lobe of a patient with AD. Western blotting and immunofluorescence staining were subsequently performed to uncover the potential preventive role of Nrg1 in cortical neurons affected by the neurodegenerative processes of AD. It was observed that the expression of Nrg1 increased as the culture time of the cortical neurons progressed. In addition, H2O2 and Aß1­42, two inducers of oxidative stress and neuronal damage, led to a dose­dependent decrease in Nrg1 expression. Recombinant Nrg1ß, however, was revealed to exert a pivotal role in preventing oxidative stress and neuronal damage from occurring in the mouse cortical neurons. Taken together, these results suggest that changes in Nrg1 signaling may influence the pathological development of AD, and exogenous Nrg1 may serve as a potential candidate for the prevention and treatment of AD.


Assuntos
Doença de Alzheimer/metabolismo , Lobo Frontal/metabolismo , Neuregulina-1/metabolismo , Transdução de Sinais , Doença de Alzheimer/patologia , Peptídeos beta-Amiloides/metabolismo , Animais , Senescência Celular , Progressão da Doença , Feminino , Lobo Frontal/patologia , Humanos , Masculino , Camundongos , Neurônios/metabolismo , Estresse Oxidativo , Fosforilação , Agregação Patológica de Proteínas/metabolismo , Ligação Proteica , Isoformas de Proteínas , Receptor ErbB-4/metabolismo
12.
Mol Med Rep ; 14(1): 790-6, 2016 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-27220549

RESUMO

Neuregulin 1 (Nrg1) is involved in multiple biological processes in the nervous system. The present study investigated changes in Nrg1 signaling in the major brain regions of mice subjected to lipopolysaccharide (LPS)-induced neuroinflammation. At 24 h post­intraperitoneal injection of LPS, mouse brain tissues, including tissues from the cortex, striatum, hippocampus and hypothalamus, were collected. Reverse transcription­polymerase chain reaction was used to determine the expression of Nrg1 and its receptors, Neu and ErbB4, at the mRNA level. Western blotting was performed to determine the levels of these proteins and the protein levels of phosphorylated extracellular signal-regulated kinases (Erk)1/2 and Akt1. Immunohistochemical staining was utilized to detect the levels of pNeu and pErbB4 in these regions. LPS successfully induced sites of neuroinflammation in these regions, in which changes in Nrg1, Neu and ErbB4 at the mRNA and protein levels were identified compared with controls. LPS induced a reduction in pNeu and pErbB4 in the striatum and hypothalamus, although marginally increased pErbB4 levels were found in the hippocampus. LPS increased the overall phosphorylation of Src but this effect was reduced in the hypothalamus. Moreover, increased phosphorylation of Akt1 was found in the striatum and hippocampus. These data suggest diverse roles for Nrg1 signaling in these regions during the process of neuroinflammation.


Assuntos
Encéfalo/metabolismo , Encefalite/etiologia , Encefalite/metabolismo , Lipopolissacarídeos/efeitos adversos , Neuregulina-1/metabolismo , Transdução de Sinais , Animais , Encéfalo/patologia , Modelos Animais de Doenças , Encefalite/patologia , Feminino , Expressão Gênica , Imuno-Histoquímica , Camundongos , Neuregulina-1/genética , Fosforilação , Proteínas Proto-Oncogênicas c-akt/metabolismo , Receptor ErbB-2/genética , Receptor ErbB-2/metabolismo , Receptor ErbB-4/genética , Receptor ErbB-4/metabolismo
13.
Restor Neurol Neurosci ; 34(2): 325-35, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26889968

RESUMO

PURPOSE: The aim of the study was to investigate the functional role of L1.2, the zebrafish paralog of L1.1 and ortholog of mammalian L1CAM in adult zebrafish spinal cord regeneration after injury. L1CAM and L1.1 have shown beneficial features in ameliorating nervous system dysfunctions in different experimental paradigms. It thus deemed important to characterize the L1.2 member of the L1CAM family, the functions of which are unknown. METHODS: Spinal cord transection of adult zebrafish, application of anti-sense morpholino to reduce L1.2 expression, qPCR, immunohistology, immunoblotting, in situ hybridization, retrograde tracing, anterograde tracing. RESULTS: Similar to L1.1, L1.2 expression in adult zebrafish is upregulated after spinal cord transection. By co-localization of in situ hybridization and immunohistology, L1.2 is expressed in neurons and, in contrast to L1.1, it is also expressed in GFAP-immunoreactive glia. Reducing L1.2 protein levels leads to impaired locomotor recovery and reduction of regrowth of severed descending axons from a brain stem nucleus which is composed of neurons innately capable of axonal regrowth. CONCLUSIONS: Our findings support the speculation that paralogs of duplicated genes can exert similar functions and may thus represent an advantage over other species that do not carry duplicated genes.


Assuntos
Molécula L1 de Adesão de Célula Nervosa/metabolismo , Recuperação de Função Fisiológica/fisiologia , Traumatismos da Medula Espinal/fisiopatologia , Regeneração da Medula Espinal/fisiologia , Regulação para Cima/fisiologia , Análise de Variância , Animais , Axônios/efeitos dos fármacos , Axônios/metabolismo , Modelos Animais de Doenças , Proteína Semelhante a ELAV 3/metabolismo , Proteína Glial Fibrilar Ácida/metabolismo , Proteínas com Homeodomínio LIM/genética , Proteínas com Homeodomínio LIM/metabolismo , Locomoção/efeitos dos fármacos , Lisina/análogos & derivados , Lisina/metabolismo , Morfolinos/farmacologia , Molécula L1 de Adesão de Célula Nervosa/genética , RNA Mensageiro/metabolismo , Recuperação de Função Fisiológica/efeitos dos fármacos , Traumatismos da Medula Espinal/metabolismo , Natação/fisiologia , Fatores de Transcrição/genética , Fatores de Transcrição/metabolismo , Regulação para Cima/efeitos dos fármacos , Peixe-Zebra
14.
Neurosci Lett ; 584: 331-6, 2015 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-25445362

RESUMO

The neural cell adhesion molecule L1 (L1CAM) is crucial for the development of the nervous system, with an essential role in regulating multiple cellular activities. Protein kinase D1 (PKD1) serves as a key kinase given its diverse array of functions within the cell. Here, we investigated various aspects of the functional relationship between L1 and phosphorylated PKD1 (pPKD1) in cerebellar granule neurons. To study the relationship between L1 and PKD1 phosphorylation, human cerebellar tissue microarrays were subject to immunofluorescence staining. We observed a positive correlation between L1 protein levels and PKD1 phosphorylation. In addition, L1 also co-localized with pPKD1. To analyze the regulatory role of L1 on PKD1 phosphorylation, primary mouse cerebellar granule neurons were treated with various concentrations of rL1 for 48 h. Using Western blot, we revealed that L1 significantly increased PKD1 phosphorylation compared with vehicle control, with the maximal effect observed at 5 nM. ERK1/2 phosphorylation was significantly increased by 2.5 nM and 10nM L1, with no apparent change in SRC phosphorylation. However, SRC expression was markedly reduced by 10nM rL1. AKT1 expression and phosphorylation levels were significantly increased by rL1, with the maximal effect observed at 2.5 and 5 nM, respectively. Our combined data revealed a positive relationship between L1 and pPKD1 in both cultured cerebellar neurons and human cerebellar tissue, suggesting that L1 functions in the modulation of PKD1 phosphorylation.


Assuntos
Cerebelo/metabolismo , Complexo Antígeno L1 Leucocitário/metabolismo , Neurônios/metabolismo , Proteína Quinase C/metabolismo , Canais de Cátion TRPP/metabolismo , Animais , Células Cultivadas , Cerebelo/citologia , Humanos , Camundongos Endogâmicos C57BL , Neurônios/citologia , Fosforilação , Transdução de Sinais
15.
J Zhejiang Univ Sci B ; 15(12): 1088-92, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-25471839

RESUMO

Though postgraduate education started before the founding of new China in 1949, it was not until the implementation of the policy reform and the opening-up in 1978 that China's postgraduate productivity began to take off. Since the introduction of Regulations of the People's Republic of China on Academic Degrees in 1981, the number of graduate students enrolled each year has increased 50 times since 1978. China is now the second largest producer of publications indexed by the database of Science Citation Index (SCI) (Web of Science™, Thomson Reuters), which reflects great strides being made in the postgraduate education. In this paper, we discuss the relationship between the increasingly high enrollments of graduate students and the quantity (the number) and quality (the academic impact and the originality) of their publications, to see whether there is a correlation.


Assuntos
Educação de Pós-Graduação , Ciência/educação , China , Humanos , Publicações , Editoração/tendências , Universidades
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...